SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-005283
Filing Date
2020-05-06
Accepted
2020-05-06 07:14:53
Documents
13
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20200506x8k.htm   iXBRL 8-K 38196
2 EX-99.1 bpmc-20200506xex99d1.htm EX-99.1 110651
  Complete submission text file 0001558370-20-005283.txt   280959

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20200506.xsd EX-101.SCH 3292
4 EX-101.LAB bpmc-20200506_lab.xml EX-101.LAB 15499
5 EX-101.PRE bpmc-20200506_pre.xml EX-101.PRE 10528
11 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20200506x8k_htm.xml XML 4633
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 20851118
SIC: 2834 Pharmaceutical Preparations